Published on 8 Feb 2024 on Simply Wall St. via Yahoo Finance
As you might know, Mesa Laboratories, Inc. (NASDAQ:MLAB) recently reported its quarterly numbers. It looks to have been a decent result overall - while revenue fell marginally short of analyst estimates at US$53m, statutory earnings beat expectations by a notable 875%, coming in at US$0.39 per share. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.
Check out our latest analysis for Mesa Laboratories
earnings-and-revenue-growth